Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesday, a key element in President Joe Biden's push to lower health care costs ahead of the 2024 election.
Oct 3, 2023
0
0
The Canadian government is proposing a new "Agile Licensing" framework to expedite pre-market regulation of pharmaceuticals. While Health Minister Jean-Yves Duclos claims this is part of the government's strategy to offer ...
Jun 27, 2023
0
7
Under-fire Dutch medical device maker Philips said Wednesday extensive testing on its recalled respirator devices showed they were "within safety limits" for use, but that a final verdict rests with global regulatory authorities.
Dec 21, 2022
0
2
The pharmaceutical industry is targeting vulnerable Americans with predatory pricing that is forcing them to ration life-saving drugs, according to a three-year congressional probe released Friday.
Dec 10, 2021
0
13
Aduhelm, the first new Alzheimer's drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works, says Rachel Sachs, ...
Dec 7, 2021
1
3
A measure designed to lower prescription drug costs for seniors has been added to President Joe Biden's social safety net and climate change bill that Democratic leaders hope to bring to a House vote this week.
Nov 3, 2021
0
1
Average annual health care spending for individuals with employer-sponsored insurance (ESI) rose 2.9% to $6,001 per person in 2019, according to the Health Care Cost Institute's annual Health Care Cost and Utilization Report. ...
Oct 6, 2021
0
7
Basing new drug launch prices on historical domestic data could limit manufacturers' power to set extremely high launch prices and could reduce Medicare spending on new drugs by up to 30%, according to a new white paper released ...
Sep 23, 2021
0
13
A new analysis of publicly reported financial information of the pharmaceutical industry finds reducing drug prices could have no impact to future drug approvals.
Aug 12, 2021
0
2
Italian pharmaceutical Leadiant has been fined almost 20 million euros for allegedly overcharging for medicine used to treat a rare cholesterol disease, the Dutch consumer watchdog said on Monday.
Jul 19, 2021
0
1
